Heart Attack clinical trials at UC Davis
1 research study open to eligible people
Showing trials for
A Study of In-Hospital Initiation of Dapagliflozin in Acute Heart Failure
“Volunteer for research and contribute to discoveries that may improve health care for you, your family, and your community!”
open to eligible people ages 18 years and up
This is an international, multicenter, parallel-group, randomized, double-blind, placebo-controlled trial in patients who have been stabilized during hospitalization for acute heart failure, evaluating the effect of in-hospital initiation of dapagliflozin versus placebo on the clinical outcome of cardiovascular death or worsening heart failure.